Correlation Between Camurus AB and Devyser Diagnostics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Camurus AB and Devyser Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Camurus AB and Devyser Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Camurus AB and Devyser Diagnostics AB, you can compare the effects of market volatilities on Camurus AB and Devyser Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Camurus AB with a short position of Devyser Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Camurus AB and Devyser Diagnostics.

Diversification Opportunities for Camurus AB and Devyser Diagnostics

-0.34
  Correlation Coefficient

Very good diversification

The 3 months correlation between Camurus and Devyser is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Camurus AB and Devyser Diagnostics AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Devyser Diagnostics and Camurus AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Camurus AB are associated (or correlated) with Devyser Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Devyser Diagnostics has no effect on the direction of Camurus AB i.e., Camurus AB and Devyser Diagnostics go up and down completely randomly.

Pair Corralation between Camurus AB and Devyser Diagnostics

Assuming the 90 days trading horizon Camurus AB is expected to generate 1.21 times more return on investment than Devyser Diagnostics. However, Camurus AB is 1.21 times more volatile than Devyser Diagnostics AB. It trades about -0.17 of its potential returns per unit of risk. Devyser Diagnostics AB is currently generating about -0.29 per unit of risk. If you would invest  61,500  in Camurus AB on September 13, 2024 and sell it today you would lose (5,200) from holding Camurus AB or give up 8.46% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Camurus AB  vs.  Devyser Diagnostics AB

 Performance 
       Timeline  
Camurus AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Camurus AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Devyser Diagnostics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Devyser Diagnostics AB are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Devyser Diagnostics may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Camurus AB and Devyser Diagnostics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Camurus AB and Devyser Diagnostics

The main advantage of trading using opposite Camurus AB and Devyser Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Camurus AB position performs unexpectedly, Devyser Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Devyser Diagnostics will offset losses from the drop in Devyser Diagnostics' long position.
The idea behind Camurus AB and Devyser Diagnostics AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Stocks Directory
Find actively traded stocks across global markets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.